Sinovac Biotech Ltd
Welcome to Chinasecurities
May 24, 2009
HOT OFF THE CHINA SECURITIES BLOG .... 1. Canadian Solar (NASDAQ:CSIQ) - 4Q09 net revenues of $287.0 million
2. Gulf Resources (NASDAQ:GFRE) - Net income was $30.6 million, or $1.00 per basic and diluted share, a year-over-year increase of 36.6% from $22.4 million
3. DEER Consumer Products (NASDAQ:DEER) - Record Revenue of $81.3 million, an increase of 86% from $43.8 million in 2008
Mr. Weidong Yin has been the President, CEO, Secretary and a Director of the Company since September 24, 2003. Mr. Yin is also the General Manager of the Company’s subsidiary, Sinovac Biotech Co., Ltd. Mr. Weidong Yin, has been dedicated to hepatitis research for over 20 years. He is credited with developing the intellectual property that led to the development of the Company’s hepatitis A vaccine. In addition, Mr. Yin has been appointed to be the principal investigator by the Chinese Ministry of Science and Technology for many key governmental R&D programs such as “Inactivated Hepatitis A vaccine R&Dâ€, “Inactivated SARS vaccine R&D†and “New Human Influenza Vaccine (H5N1) R&Dâ€. He obtained his Masters degree in Business Administration from the Singapore State University.
Mr. Xianping Wang (Age 47) is a director nominee and has been the President and CEO of Xinhua China Ltd. since September 2004, which is a reporting issuer and is listed on the National Association of Securities Dealers Over-the-Counter Bulletin Board having the symbol “XHUAâ€. He is also President of Asia-Durable (Beijing) Investments Co., Ltd. since 2002, the President of Beijing New Fortune Investment Co., Ltd. from 1997-2002, and General Manager of Beijing Fuhua Constructions and Development Co., Ltd. from 1992-1997. Mr. Wang has obtained two university degrees, one was an Engineer Bachelor Degree from Navy Engineering Institute, and the other one was an Economy Master Degree from Tsinghua University. After graduation from university, Mr. Wang dedicated diversity industries, such as bio-medicine, healthy industry, construction projects, investment consultation and real estate development as well as other related industries. Since 1993, he has participated in varied real estate investment projects in China, managing the development of Fuhua Mansion, Meihui Mansion and Jinhua Garden, including others, with a total marketable area of 600,000 square meters.
Ms. Cathy Mok Chup Hung (“Mokâ€) (age 48) is a director nominee and is currently the Financial Controller of Zero Spot Laundry Service Private Limited where she is responsible for the financial affairs of that company and also leads the human resource management function. Prior to joining Zero Spot Laundry Service Private Limited, Mok had more than 28 years of banking experience. Mok joined Bank of China, Singapore Branch in January 2002. During that period, she lead the Internal Audit and Treasury Settlements functions. Mok was also a member of the bank’s Assets and Liabilities Management Committee, Prevention of Money Laundering Committee and Business Continuity Management Committee. Prior to joining Bank of China, Mok began her career with The Kwangtung Provincial Bank Singapore Branch. During that period, she worked in the retail banking division. Mok was also responsible for setting up the Kwangtung Provincial Bank’s Treasury Department. From 1992 to 2001, being the senior management member of the bank, she had oversight responsibilities in accounting, treasury settlements, human resource management and credit management functions. In addition, Mok was a member of Kwangtung Provincial Bank’s Credit Committee and Prevention of Money Laundering Committee. Mok holds a Master of Business Administration from the National University of Singapore.
Mr. Simon Anderson has been a Director of the Company since July 23, 2004. Mr. Anderson has been a partner and Vice President of MCSI Consulting Services Inc. from 1996 to present. Mr. Anderson is a Chartered Accountant and a Chartered Business Valuator and from 1994 to 1996 was a partner with BDO Dunwoody, an international accounting and consulting firm, where he specialized in mergers, acquisitions and valuations. Mr. Anderson was admitted as a member of the Institute of Chartered Accountants in British Columbia in 1986. He has also been a member of the Canadian Institute of Charter Business Valuators since 1990. In addition, Mr. Anderson is a director and/or Chief Financial Officer of four other public companies.
Mr. Lo Yuk Lam (age 58) is a director nominee and is presently the Vice President of PerkinElmer Life and Analytical Sciences, Pacific Rim, the Chairman of the Chinese Manufacturers’ Association of Hong Kong – Industry Technology Committee, and the Director of the Chinese Manufacturers’ Association of Hong Kong. Professor Lo was the Chairman of the Innovation and Technology Fund (Biotechnology Projects) Vetting Committee, HKSAR, and of the Biotechnology Committee, Industry & Technology Development Council, HKSAR. He was also the Director of the Hong Kong Applied R&D Fund Co., Ltd., HKSAR. Prof. Lo was heavily involved in several committees of the Industry Department of the HKSAR Government. Prof. Lo has been awarded the Honorary Fellow by the Hong Kong University of Science and Technology and the Honorary Chairman of the City University Committee of Co-operative Education Centre. Prof. Lo has extensively served the societies of Greater China. He is currently a Member of the Advisory Committee of the World Trade Centre Association (Hong Kong), an Adjunct Professor of the Chinese University of Hong Kong, the Special Advisor of the Hong Kong University of Science & Technology (HKUST), a Committee Member of the Biotechnology Research Institute (BRI) of HKUST, and a Member of the Advisory Committee of the City University of Hong Kong and the Hong Kong Polytechnic University. In Mainland China, Prof. Lo is the Consultant of the Economic Bureau, Changchun, a Member of the Advisory Committee of the Shenzhen Municipal Science and Technology Bureau, the Honorary Consultant of the Beijing Medical University, the Honorary Professor of Chengdu University of TCM and the Visiting Professor of the Xiamen University China and the Shanghai Jiao Tong University.
---- In charge of Production Dept., Engineering Dept., Development Dept., and Quality Assurance Dept.;
Deputy General Manager of Tangshan Yian Biological Engineering Co., Ltd.
---- In charge of P3 Lab;
Mr. Zhang has had sophisticated training courses on Biological product manufacturing management and quality control in Holland and received training on biological product manufacturing management and quality control at Merck. He fully understands European GMP standards, which was used into manufacturing workshop construction of inactivated hepatitis A vaccine and split flu vaccine, which guides the production management and quality control of Sinovac to meet international standards.
Previously he was:
Production manager & Senior Manager of Shenzhen Kangtai Biological Product Co., Ltd.
Vice General Manager of Shenzhen Guangxin Biological Product Co., Ltd.
Consultant of Tangshan Yian Biological Engineering Co., Ltd.
Production manager of Shenzhen Kangtai iological Product Co., Ltd.
Vaccine researcher in Wuhan Biological Institute.
Education:
EMBA from Tsinghua University, Bachelor in Medical Treatment from Sun Yat-sen University of Medical Sciences, Guangzhou, PRC China.
Sun Yat-sen University of Medical Sciences, Bachelor in Medical Treatment;
---- In charge of Business Development Dept. and Clinical Research Dept.
Ms. Wang has over 10 years of experience in the field of business development, project research and registration management,. working with China Bioway Biotech Group and Shenzhen Kexing Biological Product Co., Ltd. She has conducted studies on development strategy of biological enterprises. And at the same time she knows well about government policy relating to drug R&D and registration. She also holds very good relationship with related government officials.
Previously she was:
Researcher in Live Science College of Peking University;
China Bioway Biotech Group;
Shenzhen Kexing Biological Product Co., Ltd.
Education:
University of International Business and Economics, Master in Enterprise Management;
Peking University, Bachelor of Science in Biology;
Gain Diploma in Financial Management in the course of ACCA organized in China
--- In charge of Sales Dept, Marketing Dept, and Business Dept;
He has been the Sales Director of Changchun Changsheng Biological Product Co., Ltd. for 11 years in charge of vaccine marketing with a strong focus on Hepatitis A. He was appointed subsequently as the Vice President of Shenzhen Shukang Biological Products Co. Ltd. responsible for marketing and sales of vaccines and blood products. Since Sinovac’s incorporation, he contributed to building up the company’s sales team and network and responsible for the sale of Sinovac vaccines.
Previously he was:
Assistant to Director of Blood research section of Institute of Changchun Biological Products, Ministry of Public Health, P.R. China.
Sales Manager of Changchun Changsheng Industrial Co., Ltd.
Vice General Manager of Shenzhen Shukang Biology Co., Ltd.
Education:
Graduated from Norman Bethune University of Medical Sciences.
She is a Pharmaceutical engineer. And she gained certified Professional Pharmacist in 1995. She has the experience of vaccine R&D for over 10 years. She used to work in quality assurance department of Tangshan Yian. She dedicated to the R&D of Hepatitis A vaccine and Hepatitis A&B vaccine. She is a professional in establishing the method of quality control, quality assurance, clinical trial of the vaccine and the registration for the new bio-products. After that, she also participated into the establishment of GMP administrative system of inactivated hepatitis A vaccine. And she is in charge of the registration for split flu vaccine development by Sinovac. She was certified to be senior engineer in late 2002. Currently she is the assistant to CEO. And she is in charge of QA dept. and QC dept.
Education Background
Shen Yang Pharmaceuticals College, bachelor of chemical pharmaceuticals.
Training course on GMP investigator for vaccine organized by WHO.
Working Experience:
2005 – now Sinovac Biotech Ltd. Senior Manager, Manager of Human Resource Department, Assistant to CEO
2001 – 2005 Sinovac Biotech Ltd. Manager of Human Resource Department
1998 – 2001 Tangshan Yian Biological Engineering Co., Ltd. Manager of Administration and Human Resource
1992 – 1998 Tangshan Biomedical Technology Development Co., Ltd. Administration Manager
Education:
1998 – 2001 RINMIN UNIVERSITY OF CHINA Master of Industrial Economics
1985 – 1989 YANSHAN UNIVERSITY Bachelor in forge technique and equipment
